Fintel reports that on April 8, 2025, William Blair initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Outperform recommendation. Analyst Price Forecast Suggests 195.25% Upside As of ...

Healthcare Analysts, along with argenx ( ARGX) SE CEO Tim Van Hauwermeiren and Dr. Chafic Karam discuss Vyvgart on an Analyst/Industry conference call to be held on April 8 at 1 pm. Published first on ...

Fintel reports that on April 4, 2025, William Blair initiated coverage of Savers Value Village (NYSE:SVV) with a Outperform ...

Equities researchers at William Blair issued their Q2 2025 earnings per share (EPS) estimates for shares of Rekor Systems in ...

Since the yoga-wear maker makes most of its products in countries targeted with outsize tariffs, William Blair says the ...

Investment analysts at William Blair issued their Q1 2025 earnings per share (EPS) estimates for shares of Rekor Systems in a ...

Investing.com -- William Blair remains optimistic on Tesla (NASDAQ: TSLA) despite recent setbacks, forecasting that shares ...

On Thursday, William Blair initiated coverage on Waste Connections Inc . (NYSE:WCN) with an Outperform rating, signaling confidence in the company’s growth potential. The company, currently ...

William Blair analyst Margaret Kaczor maintained a Hold rating on Neuronetics (STIM – Research Report) today. The company’s shares closed ...

The high-end athleisure brand is “in the tariffs bullseye” – with the bulk of its manufacturing sourced from countries hit hard by the new reciprocal levies, according to an analyst.

Tesla shares fell more than 5% on Wednesday, ending the EV maker's blistering rebound out of a prolonged slump.

The industry supplies low-cost clothing to the United States, and is a crucial part of the Asian countries’ economies.